Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | ESR1 | P03372 | 2/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | KCNN4 | O15554 | 4/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.36 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL863162 | 0.79 | KDM4E (0.44) | CYP2C9CYP1A2ALDH1A1ESR1ESR2 | |
| SCHEMBL9302742 | 0.79 | ESR1 (0.48) | ALDH1A1ESR1ESR2CYP3A4MAPT | |
| SCHEMBL2172033 | 0.77 | MEN1 (0.52) | CYP1A2CYP3A4MAPTKMT2ATSHR | |
| SCHEMBL3825948 | 0.77 | KCNN4 (0.46) | CYP2C9CYP2C19CYP3A4MAPTKMT2A | |
| SCHEMBL28628134 | 0.76 | CYP1A2 (0.41) | CYP2C9CYP1A2ALDH1A1ESR1ESR2 | |
| SCHEMBL11516565 | 0.75 | LMNA (0.58) | CYP1A2CYP2C19PTPN1MAPTHIF1A | |
| SCHEMBL10837928 | 0.75 | ESR1 (0.46) | CYP2C9CYP1A2ALDH1A1ESR1ESR2 | |
| SCHEMBL2158327 | 0.75 | ESR1 (0.46) | CYP2C9CYP1A2ALDH1A1ESR1ESR2 | |
| SCHEMBL1814746 | 0.75 | KCNN4 (0.46) | CYP2C9CYP1A2ALDH1A1ESR1ESR2 | |
| SCHEMBL28018612 | 0.75 | PTPN1 (0.46) | CYP2C9CYP1A2ALDH1A1PTPN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118063847-A | High-sensitivity wearable chronic kidney disease detection gel and preparation method and application thereof | 华南理工大学 | 2024-05-24 | — | — | CN | claimed |
| US-20140128420-A1 | NUTRITIONAL SUPPLEMENT COMPOSITIONS | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2014-05-08 | — | — | US | claimed |
| EP-1809283-A2 | MORPHINE AND MORPHINE PRECURSORS | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2007-07-25 | — | — | EP | claimed |
| US-20060088607-A1 | Nutritional supplement compositions | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2006-04-27 | — | — | US | claimed |
| WO-2006039691-A2 | MORPHINE AND MORPHINE PRECURSORS | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2006-04-13 | — | — | WO | claimed |
| EP-0632797-A4 | PREPARATION OF SUBSTITUTED OR UNSUBSTITUTED PHENYLGLYOXALS. | HOECHST CELANESE CORP (US) | 1995-05-24 | — | — | EP | claimed |
| EP-0632797-A1 | PREPARATION OF SUBSTITUTED OR UNSUBSTITUTED PHENYLGLYOXALS | HOECHST CELANESE CORPORATION (US) | 1995-01-11 | — | — | EP | claimed |
| US-5319142-A | Process for preparing substituted and unsubstituted arylalkylamines | HOECHST CELANESE CORPORATION (US) | 1994-06-07 | — | — | US | claimed |
| WO-1993017989-A1 | PREPARATION OF SUBSTITUTED OR UNSUBSTITUTED PHENYLGLYOXALS | HOECHST CELANESE CORPORATION (US) | 1993-09-16 | — | — | WO | claimed |
| US-5124489-A | Process for preparing phenethanol ethers by the reduction of corresponding phenylglyoxal acetals | HOECHST CELANESE CORPORATION (US) | 1992-06-23 | — | — | US | claimed |
| US-12577526-B2 | Massively parallel on-chip construction of synthetic microbial communities | THE BROAD INSTITUTE, INC. (US) | 2026-03-17 | — | — | US | disclosed |
| US-20250376656-A1 | MASSIVELY PARALLEL ON-CHIP CONSTRUCTION OF SYNTHETIC MICROBIAL COMMUNITIES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2025-12-11 | — | — | US | disclosed |
| US-20250176872-A1 | SYSTEMS AND METHODS FOR SENSING LEVODOPA | DEXCOM, INC. (US) | 2025-06-05 | — | — | US | disclosed |
| CN-118063847-A | High-sensitivity wearable chronic kidney disease detection gel and preparation method and application thereof | 华南理工大学 | 2024-05-24 | — | — | CN | disclosed |
| US-20230277125-A1 | BREATH-BASED THERAPEUTIC DRUG MONITORING METHOD | UNIVERSITÄTS-KINDERSPITAL BEIDER BASEL (CH) | 2023-09-07 | — | — | US | disclosed |
| WO-1993017989-A1 | PREPARATION OF SUBSTITUTED OR UNSUBSTITUTED PHENYLGLYOXALS | HOECHST CELANESE CORPORATION (US) | 1993-09-16 | — | — | WO | disclosed |
| US-5124489-A | Process for preparing phenethanol ethers by the reduction of corresponding phenylglyoxal acetals | HOECHST CELANESE CORPORATION (US) | 1992-06-23 | — | — | US | disclosed |
| US-5124489-A | Process for preparing phenethanol ethers by the reduction of corresponding phenylglyoxal acetals | HOECHST CELANESE CORPORATION (US) | 1992-06-23 | — | — | US | disclosed |
| US-5124489-A | Process for preparing phenethanol ethers by the reduction of corresponding phenylglyoxal acetals | HOECHST CELANESE CORPORATION (US) | 1992-06-23 | — | — | US | disclosed |
| US-4552680-A | Hypochlorite bleach containing surfactant and organic antifoamant | THE PROCTER & GAMBLE COMPANY (US) | 1985-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577526-B2 | Massively parallel on-chip construction of synthetic microbial communities | STUB1, SAMM50, CD14 | CYP2C9 1831/4885CYP1A2 2345/4885ALDH1A1 1629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.